Upcoming Seminar

The OSCI External Seminar Series features distinguished speakers from around the world. As part of our provincial initiative, these lectures are broadcasted to all of our centres to ensure that over 100 stem cell research programs, networked across Ontario, receive the benefit of these seminars.

Please join us for an OSCI External Seminar on Monday, June 10th at 4:00 pm for Harvey Lodish, Professor, Whitehead Institute, Cambridge, "Self-renewal of erythroid progenitor cells: molecular mechanisms and new anemia drugs". Attend in Toronto in Room #6, Lower Level, Tanz Neuroscience Building, 6 Queen's Park Circle. Unfortunately due to U of T's convocation, we will be unable to webcast this seminar.

Chat Room Instructions:

1. Go to (same link every webcast): http://eos.ic.utoronto.ca/ic-chat/
2. Log-In:
   1. User Name: your choice but please use institution in the name so we know where the question/comment is coming from i.e. Mary_Mac or John_UWO
   2. Password: none needed

Previous External Seminars

• David Traver, University of California San Diego, "Specification of hematopoietic stem cells".
• Helen Blau, Stanford University, "Stem cells and regenerative medicine: capturing the kineticon of nuclear reprogramming".
• Hitoshi Niwa, RIKEN Center for Developmental Biology, "Functional dissection of pluripotency-associated transcription factor network".
• Steven Goldman, University of Rochester Medical Center, "Glial progenitor-cell based treatment and modelling of the myelin disorders".
• David Schaffer, Professor of Chemical and Biomolecular Engineering and Director of the Berkeley Stem Cell Center, "Molecular Elucidation and Engineering of Stem Cell Fate Decisions".
• Robert Nordon, Graduate School of Biomedical Engineering, University of New South Wales, Australia, "Bioreactor manipulation of stem and progenitor cells for cellular therapies".
• Mick Bhatia, Senior Scientist & Director, McMaster Stem Cell & Cancer Research Institute, McMaster University in Hamilton, "Deriving human hematopoietic progenitors using reprogramming".
• Paul Tesar, Assistant Professor, Dept of Genetics, Case Western Reserve University in Ohio, "Stem cell programming and reprogramming technologies for myelin repair".
• Sheng Ding, Senior Investigator, Gladstone Institute of Cardiovascular Disease, "A Chemical Approach to Controlling Cell Fate".
• Rudolph Jaenisch, Founding Member, Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology, "Stem Cells & the Promise of Personalized Medicine".
• Leroy Hood, President, Institute for Systems Biology, "Systems Medicine and the Emergence of P4 Medicine".